Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 19 2013
Print RSS Feed

Breaking News

Related Searches:

June 2, 2010
Thomas L. Lloyd has been appointed director of automation for the Bioanalytical Group of CEDRA Corp.   Read More »

June 1, 2010
UK firm was advancing respiratory compounds in COPD, CF  Read More »

June 1, 2010
Breast cancer drug to get accelerated review from FDA  Read More »

June 1, 2010
New moves support Bydureon launch  Read More »

June 1, 2010
AAIPharma Services will open new laboratory facilities in Durham, NC, consolidating its Chapel Hill, NC labs into one site. "This is the first of many anticipated initiatives we are making to improve our laboratory footprint and offer our custom…  Read More »

May 28, 2010
Amgen has received approval from the EMEA for Prolia (denosumab) for osteoporosis.   Read More »

May 28, 2010
Teva Pharmaceutical Industries will discontinue manufacturing the sedation drug propofol.   Read More »

May 28, 2010
Celsis International has recently updated its Drug Master Files with the FDA to include information on testing both non-sterile and sterile raw materials, in-process solutions, and finished goods on the Celsis system.  Read More »

May 27, 2010
DPT Laboratories, Ltd. has completed a $15 million expansion at its 450,000-sq.-ft, Center of Excellence for semi-solids and liquids in San Antonio, TX.  Read More »

May 27, 2010
Thermo Fisher Scientific has signed a definitive agreement to acquire Fermentas International, a manufacturer and global distributor of molecular and cellular biology research tools, for $260 million in cash.  Read More »

May 27, 2010
iMANY and Alliance Life Sciences Consulting Group (ALSCG) have entered a strategic partnership to provide contracting solutions for life sciences firms.  Read More »

May 27, 2010
Peregrine Pharmaceuticals achieved positive results from a Phase II trial evaluating bavituximab in combination with paclitaxel and carboplatin chemotherapy in patients with advanced breast cancer.  Read More »

May 26, 2010
AMRI has plans to restructure its U.S. operations and to expand its services in Asia and Europe.   Read More »

May 26, 2010
Covidien has entered a definitive agreement to sell its Specialty Chemicals business to an affiliate of New Mountain Capital, for $280 million in cash.  Read More »

May 26, 2010
A.P. Pharma, Inc. has hired a consulting practice in regulatory affairs to lead the FDA Review Process for its lead product candidate, APF530 for the prevention of acute- and delayed-onset chemotherapy-induced nausea and vomiting.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On